[0] XOMA to Present At the CIBC World Markets Annual Health Care Conference.Medical & Health Writers/Business Editors BERKELEY, Calif.--(BW HealthWire)--Oct. 31, 2001 XOMA Ltd. (Nasdaq: XOMA), announced today that an audio version of its presentation at the CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. Annual Health Care Conference will be webcast live on Tuesday, November 6th. Listed below is a non-password protected URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. , which will allow access to the XOMA presentation. Jack Castello, Chief Executive Officer of XOMA, will deliver the presentation at 4:30 p.m. (Eastern Time) from the Plaza Hotel The Plaza Hotel in New York City is a landmark 19-story luxury hotel with a height of 250 feet (76 m) and length of 400 feet that (122 m) occupies the west side of Grand Army Plaza, from which it derives its name, and extends along Central Park South in Manhattan. in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . The URL for access to the audio-webcast and XOMA slide presentation is: http://webcast.talkpoint.com/starthere.asp?pres=16246&template= cibc&exit=http://www.xoma.com (Due to the length of this URL, you may have to cut and paste To move an object from one location to another. When the operation is complete, there is nothing left in the original location. It may refer to relocating files from one folder to another or to relocating selected text or images from one document to another. it into your browser.) The visual presentation and audio-webcast will be archived for 30 days. XOMA develops and manufactures innovative biopharmaceuticals for disease targets that include cancer, immunological and inflammatory disorders and infectious diseases. In addition to its Xanelim (TM) collaboration with Genentech, Inc., XOMA's late-stage programs include collaborations with Baxter Healthcare Corporation to develop NEUPREX(R) (rBPI-21) for multiple indications (Phase II and III), and Onyx Pharmaceuticals, Inc. to develop and manufacture its CI-1042 product for cancer (Phase II and III). Earlier-stage development programs include compounds for cancer, autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause , infections and retinopathies Retinopathies Definition Retinopathy is a noninflammatory disease of the retina. There are many causes and types of retinopathy. Description . For more information about XOMA's pipeline and activities, please visit the Company's web site at www.xoma.com. Statements made in this news release related to collaborative agreements and current plans for product development or that otherwise relate to future periods, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions that may not prove accurate. Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market. These risks, including those related to changes in the status of existing collaborative relationships, the timing or results of pending and future clinical trials, the ability of collaborators and other partners to meet their obligations, market demand for products, actions by the Food and Drug Administration or the U.S. Patent and Trademark Office and uncertainties regarding the status of biotechnology patents, are discussed in XOMA's most recent annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and in other SEC filings. Consider such risks carefully in evaluating XOMA's prospects. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion